Federated Hermes Inc. Trims Holdings in Teleflex Incorporated (NYSE:TFX)

Federated Hermes Inc. cut its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 6.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 58,975 shares of the medical technology company's stock after selling 3,875 shares during the quarter. Federated Hermes Inc. owned 0.13% of Teleflex worth $10,496,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of the company. HighTower Advisors LLC lifted its stake in Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock valued at $986,000 after buying an additional 66 shares in the last quarter. Hengehold Capital Management LLC raised its holdings in shares of Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock worth $229,000 after acquiring an additional 88 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after acquiring an additional 94 shares in the last quarter. Isthmus Partners LLC lifted its position in shares of Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock valued at $273,000 after acquiring an additional 105 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Teleflex by 2.4% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company's stock valued at $888,000 after acquiring an additional 118 shares during the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

TFX has been the topic of a number of recent research reports. Wells Fargo & Company reduced their target price on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and reduced their price objective for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Piper Sandler restated a "neutral" rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Morgan Stanley cut their price target on Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, March 5th. Finally, Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and reduced their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Teleflex presently has a consensus rating of "Hold" and a consensus target price of $181.50.

Teleflex Trading Up 0.1 %

NYSE:TFX traded up $0.15 on Wednesday, hitting $128.66. 51,321 shares of the stock were exchanged, compared to its average volume of 1,057,578. The stock has a market cap of $5.97 billion, a PE ratio of 25.58, a PEG ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a fifty-two week low of $124.66 and a fifty-two week high of $249.90. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a fifty day moving average of $146.22 and a 200-day moving average of $179.92.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. As a group, equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.06%. Teleflex's dividend payout ratio is currently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.